CRP and Abdominal obesity: Our findings suggest that fractalkine plays a potential role in the pathogenesis of MetS that is independent of its relationship with central obesity as reflected by VFA, insulin resistance as reflected by HOMA-IR, systemic inflammation as reflected by CRP, and dyslipidemia as reflected by TG and HDL-c.